Elevance Health, Inc.
ELV
$390.05
$7.822.05%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -17.06% | 222.49% | -53.99% | -31.78% | -20.16% |
| Total Depreciation and Amortization | 3.39% | 189.17% | -202.58% | 1.84% | 1.88% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 109.87% | -29.28% | -211.65% | 107.38% | -39.43% |
| Change in Net Operating Assets | -98.50% | 607.63% | 30.13% | -244.04% | 87.79% |
| Cash from Operations | -55.84% | 5,057.14% | -92.60% | -44.74% | 101.97% |
| Capital Expenditure | -22.13% | 19.80% | 18.61% | -34.83% | -36.22% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -100.00% | -84.85% | 3,200.00% | -98.00% | 1,150.00% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 131.59% | -295.03% | 183.70% | -84.04% | -259.32% |
| Cash from Investing | 109.68% | -453.88% | 137.91% | -78.17% | -766.99% |
| Total Debt Issued | -106.75% | -33.40% | -56.02% | 1,256.32% | -68.78% |
| Total Debt Repaid | 58.38% | -278.60% | 73.82% | -1,981.82% | 108.06% |
| Issuance of Common Stock | -29.73% | -36.21% | -- | -- | -- |
| Repurchase of Common Stock | 79.71% | -145.34% | 45.56% | -191.92% | 70.39% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 0.80% | 0.27% | 1.05% | 1.04% | 0.26% |
| Other Financing Activities | 500.00% | -125.00% | -42.86% | 600.00% | 121.43% |
| Cash from Financing | 40.60% | -1,165.68% | -2.88% | 178.90% | 83.87% |
| Foreign Exchange rate Adjustments | 66.67% | -50.00% | -500.00% | -200.00% | 0.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 246.39% | -78.66% | 408.50% | -85.57% | 234.52% |